↓ Skip to main content

Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study)

Overview of attention for article published in BMC Infectious Diseases, February 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
43 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study)
Published in
BMC Infectious Diseases, February 2019
DOI 10.1186/s12879-019-3817-6
Pubmed ID
Authors

Juan Pasquau, Samantha E. de Jesus, Piedad Arazo, María J. Crusells, María J. Ríos, Fernando Lozano, Javier de la Torre, María J. Galindo, Jorge Carmena, Jesús Santos, Carlos Tornero, Guillermo Verdejo, Gloria Samperiz, Zaira Palacios, Carmen Hidalgo-Tenorio

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 43 100%

Demographic breakdown

Readers by professional status Count As %
Other 5 12%
Student > Master 5 12%
Researcher 4 9%
Student > Bachelor 4 9%
Student > Doctoral Student 3 7%
Other 9 21%
Unknown 13 30%
Readers by discipline Count As %
Medicine and Dentistry 13 30%
Neuroscience 3 7%
Biochemistry, Genetics and Molecular Biology 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Nursing and Health Professions 2 5%
Other 5 12%
Unknown 16 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2019.
All research outputs
#4,252,935
of 23,142,049 outputs
Outputs from BMC Infectious Diseases
#1,380
of 7,761 outputs
Outputs of similar age
#91,314
of 353,552 outputs
Outputs of similar age from BMC Infectious Diseases
#42
of 178 outputs
Altmetric has tracked 23,142,049 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,761 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,552 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 178 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.